financetom
Business
financetom
/
Business
/
Cboe profit rises as market volatility boosts hedging activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cboe profit rises as market volatility boosts hedging activity
Aug 1, 2025 5:06 AM

Aug 1 (Reuters) - Derivatives exchange Cboe Global

Markets ( CBOE ) reported a rise in second-quarter profit on

Friday, as looming economic uncertainties fueled market turmoil

and boosted options trading.

Investors and portfolio managers rushed to hedge their

positions during the period, responding to a spike in market

volatility fueled by renewed geopolitical tensions in the Middle

East and unpredictable trade policies from U.S. President Donald

Trump. That typically leads to a surge in trading volumes,

driving up transaction and clearing fees for exchanges.

Cboe's options trading business revenue jumped 19% to $364.8

million, while Europe and Asia Pacific revenue climbed 30% to

$70 million.

The company has "achieved another quarter of record net

revenue and strong adjusted earnings growth, highlighting the

durability across our exchange ecosystem", said Chief Financial

Officer Jill Griebenow.

Average daily volume in index options hit 4.7 million

contracts during the quarter ended June 30, compared with 4

million a year earlier.

Cboe wrapped up a strong quarter for exchanges across the

country such as CME Group ( CME ), Nasdaq and

Intercontinental Exchange ( ICE ).

The company's net revenue rose 14% to a record high of

$587.3 million.

Its adjusted net income rose to $257.8 million, or $2.46 per

share, from $226.2 million, or $2.15 per share, a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Interactive Brokers Chairman Thomas Peterffy Discloses 25.9% Stake in Newsmax
Interactive Brokers Chairman Thomas Peterffy Discloses 25.9% Stake in Newsmax
Apr 2, 2025
06:28 AM EDT, 04/02/2025 (MT Newswires) -- Interactive Brokers Group ( IBKR ) Founder and Chairman Thomas Peterffy disclosed a stake of about 23 million shares in Newsmax ( NMAX ) in a Tuesday filing. The 25.9% ownership is held indirectly through Conyers Investments, making Peterffy the second largest shareholder of the company, according to Investing.com. The stake is worth...
Amber's Nasdaq Debut Signals IPO Wave for Crypto Firms, Pantera's Veradittakit Says
Amber's Nasdaq Debut Signals IPO Wave for Crypto Firms, Pantera's Veradittakit Says
Apr 2, 2025
Amber Group's (AMBR) listing on Nasdaq earlier this month paves the way for more crypto companies to take the same path, said Paul Veradittakit, a partner at Pantera Capital. Pantera was an early investor in the Hong Kong-based provider of crypto financial services to institutions, whose subsidiary Amber International ( AMBR ) listed on the exchange on March 13. Public...
Mitsubishi UFG Says Canadian Dollar, Other Currencies, May Not Continue Outperforming If U.S. Tariffs More Aggressive
Mitsubishi UFG Says Canadian Dollar, Other Currencies, May Not Continue Outperforming If U.S. Tariffs More Aggressive
Apr 2, 2025
06:33 AM EDT, 04/02/2025 (MT Newswires) -- President Donald Trump's so-called Liberation Day has arrived and an announcement is scheduled for the Rose Garden at 4 p.m. ET Wednesday when all will be revealed in terms of the tariff actions against the United States' trading partners, said MUFG. President Trump stated on Sunday that the plan will cover essentially all...
Johnson & Johnson Expects Lower Earnings Impact From Intra-Cellular Therapies Acquisition
Johnson & Johnson Expects Lower Earnings Impact From Intra-Cellular Therapies Acquisition
Apr 2, 2025
06:35 AM EDT, 04/02/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) expects its pending acquisition of Intra-Cellular Therapies (ITCI) to have a lower impact on full-year earnings than previously estimated. In January, the pharmaceutical giant struck a $14.6 billion deal to purchase Intra-Cellular, which develops treatments for central nervous system disorders. The proposed transaction was approved by Intra-Cellular's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved